Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Hai Qian

机构:Jiangsu University, Tongji University, China Pharmaceutical University, Huzhou Central Hospital, Drug Discovery Laboratory (Norway) · ORCID:0000-0002-3827-0992

发表论文 280 篇 · 总被引 4526 次 · h-index 33

代表论文

  • Discovery of Novel SHP2 ATTEC Degraders against Pancreatic Ductal Adenocarcinoma Harboring KRAS(G12D) Mutations (2025 · Journal of Medicinal Chemistry · 被引 8)
  • Structure optimization of natural product piperine to obtain novel and potent analogs with anti-inflammation pain and urate-lowering effect (2025 · European Journal of Medicinal Chemistry · 被引 6)
  • Recent advances, strategies, and future perspectives of peptide-based drugs in clinical applications (2025 · Chinese Journal of Natural Medicines · 被引 6)
  • A dual-responsive AI-designed peptide P9-conjugate disrupts E6–E6AP Interface to restore p53 and suppress HPV16-driven cervical cancer (2025 · Journal of Controlled Release · 被引 4)
  • Enzyme-Responsive Peptide-Prodrug Integrated Biphasic Microneedle Patch for Enhanced Transdermal Delivery and Hypertension Therapy (2025 · ACS Applied Materials & Interfaces · 被引 4)
  • Design, synthesis and biological activity of novel pyrimidine piperazine ureas as μ-opioid and TRPV1 dual-target ligands for pain management (2025 · European Journal of Medicinal Chemistry · 被引 3)